Sullenger BA - Search Results

1

Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis.

Naqvi I, Gunaratne R, McDade JE, Moreno A, Rempel RE, Rouse DC, Herrera SG, Pisetsky DS, Lee J, White RR, Sullenger BA. Naqvi I, et al. Among authors: sullenger ba. Mol Ther. 2018 Apr 4;26(4):1020-1031. doi: 10.1016/j.ymthe.2018.02.018. Epub 2018 Feb 23. Mol Ther. 2018. PMID: 29550075 Free PMC article.

2

Developing aptamers into therapeutics.

White RR, Sullenger BA, Rusconi CP. White RR, et al. Among authors: sullenger ba. J Clin Invest. 2000 Oct;106(8):929-34. doi: 10.1172/JCI11325. J Clin Invest. 2000. PMID: 11032851 Free PMC article. No abstract available.

3

Generation of species cross-reactive aptamers using "toggle" SELEX.

White R, Rusconi C, Scardino E, Wolberg A, Lawson J, Hoffman M, Sullenger B. White R, et al. Mol Ther. 2001 Dec;4(6):567-73. doi: 10.1006/mthe.2001.0495. Mol Ther. 2001. PMID: 11735341 Free article.

4

Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2.

White RR, Shan S, Rusconi CP, Shetty G, Dewhirst MW, Kontos CD, Sullenger BA. White RR, et al. Among authors: sullenger ba. Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5028-33. doi: 10.1073/pnas.0831159100. Epub 2003 Apr 11. Proc Natl Acad Sci U S A. 2003. PMID: 12692304 Free PMC article.

5

Therapeutic aptamers and antidotes: a novel approach to safer drug design.

Sullenger BA, White RR, Rusconi CP. Sullenger BA, et al. Ernst Schering Res Found Workshop. 2003;(43):217-23. doi: 10.1007/978-3-662-05352-2_13. Ernst Schering Res Found Workshop. 2003. PMID: 12894459 Review. No abstract available.

6

RNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpins.

Jeter ML, Ly LV, Fortenberry YM, Whinna HC, White RR, Rusconi CP, Sullenger BA, Church FC. Jeter ML, et al. Among authors: sullenger ba. FEBS Lett. 2004 Jun 18;568(1-3):10-4. doi: 10.1016/j.febslet.2004.04.087. FEBS Lett. 2004. PMID: 15196911 Free article.

7

Antidote-mediated control of an anticoagulant aptamer in vivo.

Rusconi CP, Roberts JD, Pitoc GA, Nimjee SM, White RR, Quick G Jr, Scardino E, Fay WP, Sullenger BA. Rusconi CP, et al. Among authors: sullenger ba. Nat Biotechnol. 2004 Nov;22(11):1423-8. doi: 10.1038/nbt1023. Epub 2004 Oct 17. Nat Biotechnol. 2004. PMID: 15502817

8

Retargeting mobile group II introns to repair mutant genes.

Jones JP 3rd, Kierlin MN, Coon RG, Perutka J, Lambowitz AM, Sullenger BA. Jones JP 3rd, et al. Among authors: sullenger ba. Mol Ther. 2005 May;11(5):687-94. doi: 10.1016/j.ymthe.2005.01.014. Mol Ther. 2005. PMID: 15851007 Free article.

9

A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery.

Nimjee SM, Keys JR, Pitoc GA, Quick G, Rusconi CP, Sullenger BA. Nimjee SM, et al. Among authors: sullenger ba. Mol Ther. 2006 Sep;14(3):408-15. doi: 10.1016/j.ymthe.2006.04.006. Epub 2006 Jun 9. Mol Ther. 2006. PMID: 16765093 Free article.

10

Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

McNamara JO 2nd, Andrechek ER, Wang Y, Viles KD, Rempel RE, Gilboa E, Sullenger BA, Giangrande PH. McNamara JO 2nd, et al. Among authors: sullenger ba. Nat Biotechnol. 2006 Aug;24(8):1005-15. doi: 10.1038/nbt1223. Epub 2006 Jun 25. Nat Biotechnol. 2006. PMID: 16823371

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page